Currently, there is some ambiguity in the interpretation of these markers, particularly cases in which an apparently lymphoblastic leukemia
shows limited expression of myeloperoxidase by flow cytometry not corroborated by cytochemical staining.
Modern combination chemotherapy and postinduction therapeutic intensification now yield long-term remissions in 75% of children with acute lymphoblastic leukemia
, yet 25% ultimately relapse with disease that is resistant.
8 odds ratio of developing either myeloid leukemia or lymphoblastic leukemia
ERYTECH's lead product, GRASPA([R]) for the treatment of Acute Lymphoblastic Leukemia
(ALL), holds orphan designation in Europe and the US an is in a pivotal Phase II/III clinical trial in Europe.
The company said Clofarabine Injection is a generic equivalent of Genzyme's CLOLAR Injection, a prescription medicine indicated for the treatment of paediatric patients one to 21 years old with relapsed or refractory acute lymphoblastic leukemia
after at least two prior regimens.
Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia
Acute lymphoblastic leukemia
(ALL) is the most common childhood cancer (with 2,400 cases diagnosed each year in those under age 20) and the second most common cause of mortality in children aged 1-14.
Half of the children had already been diagnosed with the disease, primarily acute lymphoblastic leukemia
The roller hockey-playing tomboy from Saugus has hardly shed a tear during treatment for acute lymphoblastic leukemia
, diagnosed in May.
Micromet (Nasdaq: MITI) announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) to expand development of the Company's lead product candidate blinatumomab in patients with acute lymphoblastic leukemia
(ALL) and various sub-types of lymphoma.
M2 EQUITYBITES-March 10, 2017-Servier awarded US FDA clearance of IND application for UCART19 in the treatment of relapsed/refractory acute lymphoblastic leukemia
M2 PHARMA-March 10, 2017-Servier awarded US FDA clearance of IND application for UCART19 in the treatment of relapsed/refractory acute lymphoblastic leukemia
Patients with acute lymphoblastic leukemia
(ALL) present most frequently with signs and symptoms of the uncontrolled growth of leukemic cells in bone marrow, lymphoid organs and other sites of extramedullary spreading such as cerebrovascular disease, pleural effusions, blindness, etc.
Robison of the University of Minnesota report that parents' chemical exposures may be associated with distinct ras mutations in their children with acute lymphoblastic leukemia